Pennsylvania State Attorney General Josh Shapiro says he’s reached a settlement agreement on key financial terms with opioid manufacturer Teva. The arrangement is the result of a multistate investigation he led for Teva’s alleged deceptive marketing practices on their opioid drugs. Actiq and Fentora are used by cancer patients. The agreement will provide up to four-billion-dollars to states and local governments.